Form S-1/A ARTELO BIOSCIENCES, INC.

Artelo Biosciences, Inc. (ARTL)
US:NASDAQ Investor Relations:
artelobio.com/investors
Company Research
Source: SEC EDGAR

Impact Snapshot
Event Time:
ARTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARTL alerts
High impacting Artelo Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ARTL
News
- Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thAccesswire
- Artelo Biosciences Reports First Quarter 2022 Financial Results And Provides Business Update [TheStreet.com]TheStreet.com
- Artelo Biosciences Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewswire
- Artelo Biosciences stock soars 40% on pre-clinical data for ART27.13 in cancer-related muscle degeneration [Seeking Alpha]Seeking Alpha
- Artelo Biosciences Reports Positive Pre-clinical Results For Lead Program In Cancer-Related Cachexia [TheStreet.com]TheStreet.com
ARTL
Sec Filings
- 5/12/22 - Form 10-Q
- 4/7/22 - Form S-8
- 3/21/22 - Form 10-KT
- ARTL's page on the SEC website